Effects of pegloticase injection: A Synthesis of Findings from 5 Studies

  1. Home
  2. Effects of pegloticase injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of pegloticase injection: A Synthesis of Findings from 5 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of pegloticase injection: A Synthesis of Findings from 5 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Pentoxifylline is a medication that has been studied for its potential benefits in various conditions. 4 investigated the effects of pentoxifylline metabolites on retinal blood flow in humans. 5 reviewed and meta-analyzed randomized controlled trials to assess pentoxifylline's effects on inflammatory markers and blood pressure, suggesting potential cardiovascular benefits. 3 explored the use of pentoxifylline as a coadjuvant treatment for interferon in multiple sclerosis patients, aiming to reduce interferon side effects and improve function. 2 examined the long-term effects of pentoxifylline on platelet function in critically ill patients, recognizing its potential to modify inflammatory responses. 1 focused on the dose-response effects of pentoxifylline on erythrocyte filterability in patients with chronic occlusive arteriosclerosis, finding significant improvements in red cell deformability with increasing doses.

Benefits and Risks

Benefit Summary

Pentoxifylline has shown potential benefits in various areas. It may improve blood flow, reduce inflammation, and enhance red blood cell flexibility. 4 , 5 , 3 , 1

Risk Summary

Pentoxifylline may impact platelet function, especially in critically ill patients. 2

Comparison of Studies

Similarities

All studies focused on different aspects of pentoxifylline's potential benefits and impacts, suggesting its involvement in blood flow, inflammation, and platelet function.

Differences

These studies varied in their focus, study population, and methodology. 4 examined retinal blood flow, 5 focused on inflammatory markers and blood pressure, 3 investigated multiple sclerosis patients, 2 studied critically ill patients, and 1 analyzed the effects on erythrocyte filterability.

Consistency and Contradictions

While the studies suggest potential benefits of pentoxifylline, further research is needed to understand the mechanisms of action and clinical significance of these effects.

Real-Life Application Notes

Pentoxifylline should only be taken as prescribed by a doctor. Self-medication is not recommended. Consult your doctor about your medical history and any other medications you are taking before starting pentoxifylline.

Limitations of Current Research

The available studies represent initial investigations into the effects of pentoxifylline, and more research is necessary. Long-term safety and efficacy require further investigation.

Future Research Directions

More detailed research is needed to understand the various effects of pentoxifylline and their underlying mechanisms. Clinical trials are essential to determine the clinical relevance and safety of pentoxifylline.

Conclusion

Pentoxifylline has potential benefits in various conditions, including blood flow improvement and inflammation reduction. However, further research is needed to establish its safety and efficacy. Consult your doctor before considering pentoxifylline.

Literature analysis of 5 papers
Positive Content
5
Neutral Content
0
Negative Content
0
Article Type
4
1
1
1
5
1.

Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies.

Author: AmbrusJ L, AnainJ M, AnainS M, AnainP M, StadlerS, MitchellP, BrobstJ A, CobertB L, SavitskyJ P

Red cell filterability increase

Pentoxifylline was found to increase red cell filterability in patients with chronic occlusive arteriosclerosis in a dose-response manner. Increases in red cell filterability were proportional to plasma levels of pentoxifylline and its metabolites.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

Does long-term continuous administration of pentoxifylline affect platelet function in the critically ill patient?

Author: BoldtJ, MüllerM, HeesenM, HeynS, HempelmannG

Anti-inflammatory response

Pentoxifylline (PTX) is a promising substance that may modify or limit inflammatory response. However, the long-term effects of PTX on platelet function remain to be elucidated.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Retracted PublicationCases where a publication has been formally withdrawn due to the discovery of serious errors or misconduct.

Language : English

3.

[Pentoxifylline: is it useful in multiple sclerosis?].

Author: PrietoJ M, DapenaD, LemaM, AresB, CacabelosP, NoyaM

Interferon side effect reduction
MS treatment

Pentoxifylline (PTX) is a phosphodiesterase inhibitor that may be a potential coadjuvant treatment for interferon in patients with multiple sclerosis. This study explores the efficacy of PTX in reducing the side effects of interferon and improving functional outcomes in patients with multiple sclerosis.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : Spanish

4.

A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans.

Author: MagnussonMarie, BergstrandIngar C, BjörkmanSven, HeijlAnders, RothBodil, HöglundPeter

Increased retinal blood flow
Decreased blood flow

Pentoxifylline significantly increased retinal blood flow in humans, and this effect was enhanced by its metabolites R-M1 and M5.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

5.

Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Author: BrieDaniel, SahebkarAmirhossein, PensonPeter E, DincaMadalina, UrsoniuSorin, SerbanMaria-Corina, ZanchettiAlberto, HowardGeorge, AhmedAli, AronowWilbert S, MuntnerPaul, LipGregory Y H, WongNathan D, RyszJacek, BanachMaciej,

Reduced CRP
Reduced TNF-α

This systematic review and meta-analysis of 15 randomized controlled trials found that pentoxifylline did not alter blood pressure or plasma IL-6 concentration, but significantly reduced circulating TNF-α and CRP concentrations. The impact of pentoxifylline on TNF-α levels was associated with treatment duration, but independent of pentoxifylline dose.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.